In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By


Validus Pharmaceuticals Inc.

Latest From Validus Pharmaceuticals Inc.

Deals Shaping The Medical Industry, January 2013

Derived from Strategic Transactions, Elsevier Business Intelligence’s premium source for tracking life sciences deal activity, the Dealmaking column is a survey of recent health care transactions listed by relevant industry segment –In Vitro Diagnostics, Pharmaceuticals, and Medical Devices – and then categorized by type –Acquisition, Alliance, or Financing.

BioPharmaceutical Medical Device

Ranbaxy launches authorised generic version of Rocaltrol

Ranbaxy Pharmaceuticals Inc, a wholly owned US subsidiary of Ranbaxy Laboratories, has launched an authorised generic version of Rocaltrol (calcitriol) in both softgel capsules and an oral liquid formulation, under an agreement with Validus Pharmaceuticals LLC.

Gynecology & Urology Metabolic Disorders
See All

Company Information

  • Industry
  • Pharmaceuticals
    • Specialty Pharmaceuticals
  • Therapeutic Areas
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Renal System
  • Alias(es)
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • Validus Pharmaceuticals Inc.
  • Senior Management
  • James Hunter, Pres. & CEO
    Richard Post, VP, Sales & Mktg.
  • Contact Info
  • Validus Pharmaceuticals Inc.
    Phone: (973) 265-2777
    119 Cherry Hill Rd.
    Ste. 310
    Parsippany, NJ 07054